STOCK TITAN

Sally Beauty Hldgs Financials

SBH
FY2025 annual
Revenue $3.7B -0.4% YoY
Net Income $195.9M +27.7% YoY
EPS (Diluted) $1.89 +32.2% YoY
Free Cash Flow $172.7M +18.8% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE September

Sally Beauty Hldgs (SBH) reported $3.7B in revenue for fiscal year 2025, down 0.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SBH FY2025

Stable sales, recovering margins, and sustained debt reduction now define a business becoming less balance-sheet constrained

Margin recovery is occurring without renewed top-line growth: revenue remained around $3.7B in FY2025, while operating margin improved to 8.9% from 7.6% in FY2024. Because gross margin also reached 51.6%, the rebound reflects better cost absorption or expense control rather than a volume-led expansion.

Deleveraging has materially changed the financing structure. Debt-to-equity fell from 4.9x in FY2021 to 1.1x in FY2025 as equity reached $794M, reducing the balance sheet's dependence on borrowed capital.

Cash generation broadly validates reported earnings: FY2025 operating cash flow was $275M against net income of $196M. After $102M of capital spending, free cash flow remained $173M, indicating the business funds meaningful reinvestment while still producing cash for financing activities.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 54 / 100
Financial Health Score 54/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Sally Beauty Hldgs's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
71

Sally Beauty Hldgs has an operating margin of 8.9%, meaning the company retains $9 of operating profit per $100 of revenue. This strong profitability earns a score of 71/100, reflecting efficient cost management and pricing power. This is up from 7.6% the prior year.

Growth
30

Sally Beauty Hldgs's revenue declined 0.4% year-over-year, from $3.7B to $3.7B. This contraction results in a growth score of 30/100.

Leverage
34

Sally Beauty Hldgs has a moderate D/E ratio of 1.09. This balance of debt and equity financing earns a leverage score of 34/100.

Liquidity
64

Sally Beauty Hldgs's current ratio of 2.26 indicates adequate short-term liquidity, earning a score of 64/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
45

Sally Beauty Hldgs has a free cash flow margin of 4.7%, earning a moderate score of 45/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
82

Sally Beauty Hldgs earns a strong 24.7% return on equity (ROE), meaning it generates $25 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 82/100. This is up from 24.4% the prior year.

Altman Z-Score Grey Zone
2.86

Sally Beauty Hldgs scores 2.86, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
8/9

Sally Beauty Hldgs passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.40x

For every $1 of reported earnings, Sally Beauty Hldgs generates $1.40 in operating cash flow ($274.8M OCF vs $195.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
5.09x

Sally Beauty Hldgs earns $5.09 in operating income for every $1 of interest expense ($327.8M vs $64.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$3.7B
YoY-0.4%
5Y CAGR+1.0%
10Y CAGR-0.4%

Sally Beauty Hldgs generated $3.7B in revenue in fiscal year 2025. This represents a decrease of 0.4% from the prior year.

EBITDA
$427.7M
YoY+9.0%
5Y CAGR+3.2%
10Y CAGR-3.1%

Sally Beauty Hldgs's EBITDA was $427.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 9.0% from the prior year.

Net Income
$195.9M
YoY+27.7%
5Y CAGR+1.2%
10Y CAGR-1.8%

Sally Beauty Hldgs reported $195.9M in net income in fiscal year 2025. This represents an increase of 27.7% from the prior year.

EPS (Diluted)
$1.89
YoY+32.2%

Sally Beauty Hldgs earned $1.89 per diluted share (EPS) in fiscal year 2025. This represents an increase of 32.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$172.7M
YoY+18.8%
5Y CAGR-11.4%
10Y CAGR-1.2%

Sally Beauty Hldgs generated $172.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 18.8% from the prior year.

Cash & Debt
$149.2M
YoY+38.2%
5Y CAGR-21.9%
10Y CAGR+0.6%

Sally Beauty Hldgs held $149.2M in cash against $862.0M in long-term debt as of fiscal year 2025.

Shares Outstanding
97M
YoY-4.3%

Sally Beauty Hldgs had 97M shares outstanding in fiscal year 2025. This represents a decrease of 4.3% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
51.6%
YoY+0.8pp
5Y CAGR+2.8pp
10Y CAGR+2.1pp

Sally Beauty Hldgs's gross margin was 51.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the prior year.

Operating Margin
8.9%
YoY+1.2pp
5Y CAGR+1.5pp
10Y CAGR-4.1pp

Sally Beauty Hldgs's operating margin was 8.9% in fiscal year 2025, reflecting core business profitability. This is up 1.2 percentage points from the prior year.

Net Margin
5.3%
YoY+1.2pp
5Y CAGR0.0pp
10Y CAGR-0.8pp

Sally Beauty Hldgs's net profit margin was 5.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.2 percentage points from the prior year.

Return on Equity
24.7%
YoY+0.3pp
5Y CAGR-1170.7pp

Sally Beauty Hldgs's ROE was 24.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the prior year.

Capital Allocation

Share Buybacks
$54.0M
YoY-10.6%

Sally Beauty Hldgs spent $54.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 10.6% from the prior year.

Capital Expenditures
$102.1M
YoY+1.0%
5Y CAGR-1.6%
10Y CAGR-0.4%

Sally Beauty Hldgs invested $102.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 1.0% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

SBH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SBH annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$3.7B$3.7B-0.4%$3.7B-0.3%$3.7B-2.3%$3.8B-1.5%$3.9B+10.3%$3.5B-9.3%$3.9B-1.4%$3.9B-0.1%$3.9B-0.4%$4.0B+3.1%$3.8B+2.2%$3.8B+3.6%$3.6B+2.8%$3.5B+7.8%$3.3B
Cost of Revenue$1.8B$1.8B-2.0%$1.8B-0.2%$1.8B-3.5%$1.9B-1.3%$1.9B+6.8%$1.8B-8.5%$2.0B-1.1%$2.0B+0.7%$2.0B-0.8%$2.0B+2.7%$1.9B+2.3%$1.9B+3.6%$1.8B+2.6%$1.8B+6.3%$1.7B
Gross Profit$1.9B$1.9B+1.1%$1.9B-0.4%$1.9B-1.1%$1.9B-1.7%$2.0B+13.9%$1.7B-10.2%$1.9B-1.7%$1.9B-1.0%$2.0B0.0%$2.0B+3.5%$1.9B+2.0%$1.9B+3.6%$1.8B+3.0%$1.7B+9.3%$1.6B
SG&A Expenses$1.6B$1.6B-1.5%$1.6B+3.3%$1.6B+0.1%$1.6B+1.5%$1.5B+6.1%$1.4B-0.7%$1.5B-2.1%$1.5B+1.4%$1.5B-0.1%$1.5B+11.6%$1.3B+3.1%$1.3B+5.9%$1.2B+2.0%$1.2B+8.5%$1.1B
Operating Income$314.2M$327.8M+15.9%$282.7M-13.0%$325.0M-3.7%$337.6M-19.3%$418.4M+61.7%$258.8M-43.6%$458.5M+7.5%$426.6M-10.9%$478.6M-4.0%$498.3M+0.6%$495.3M-2.3%$507.0M-2.6%$520.4M+4.2%$499.4M+11.3%$448.5M
Interest ExpenseN/A$64.4M-15.7%$76.4M+4.7%$73.0M-22.0%$93.5M0.0%$93.5M-5.3%$98.8M+2.6%$96.3M-1.9%$98.2M-26.1%$132.9M-7.9%$144.2M+23.4%$116.8M+0.5%$116.3M+8.0%$107.7M-22.2%$138.4M+23.0%$112.5M
Income Tax$64.5M$67.5M+27.6%$52.9M-21.6%$67.5M+11.4%$60.5M-28.8%$85.1M+82.1%$46.7M-48.4%$90.5M+28.6%$70.4M-46.1%$130.6M-0.4%$131.1M-8.6%$143.4M-0.9%$144.7M-4.5%$151.5M+18.5%$127.9M+4.6%$122.2M
Net Income$192.3M$195.9M+27.7%$153.4M-16.9%$184.6M+0.6%$183.6M-23.5%$239.9M+29.9%$184.6M-32.0%$271.6M+5.3%$258.0M+20.0%$215.1M-3.5%$222.9M-5.2%$235.1M-4.4%$246.0M-5.8%$261.2M+12.1%$233.1M+9.0%$213.7M
EPS (Diluted)$1.89+32.2%$1.43-15.4%$1.69+1.8%$1.66-21.0%$2.10$0.99$2.26+8.7%$2.08+33.3%$1.56+4.0%$1.50+0.7%$1.49-1.3%$1.51+2.0%$1.48+19.4%$1.24+8.8%$1.14

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SBH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SBH annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$2.9B+2.8%$2.8B+2.5%$2.7B+5.8%$2.6B-9.5%$2.8B-1.7%$2.9B+38.0%$2.1B0.0%$2.1B-0.1%$2.1B+0.2%$2.1B0.0%$2.1B+4.5%$2.0B+4.1%$1.9B-6.8%$2.1B+19.5%$1.7B
Current Assets$1.3B-0.3%$1.3B+6.3%$1.2B+8.4%$1.1B-18.2%$1.4B-3.5%$1.4B+23.2%$1.2B+0.7%$1.2B+1.1%$1.1B-2.6%$1.2B-1.2%$1.2B+7.5%$1.1B+8.7%$1.0B-12.7%$1.2B+32.4%$879.1M
Cash & Equivalents$149.2M+38.2%$108.0M-12.2%$123.0M+74.3%$70.6M-82.4%$401.0M-22.0%$514.2M+619.1%$71.5M-7.5%$77.3M+21.2%$63.8M-26.4%$86.6M-38.1%$140.0M+31.4%$106.6M+126.2%$47.1M-80.4%$240.2M+278.4%$63.5M
Inventory$987.6M-4.7%$1.0B+6.3%$975.2M+4.1%$936.4M+7.5%$871.3M+7.0%$814.5M-14.5%$952.9M+0.9%$944.3M+1.4%$930.9M+2.6%$907.3M+2.5%$885.2M+6.9%$828.4M+2.5%$808.3M+9.9%$735.4M+10.5%$665.2M
Accounts Receivable$31.8M-5.4%$33.6M+0.6%$33.4M-2.0%$34.1M+4.5%$32.6M-8.3%$35.6M-17.5%$43.1M-10.9%$48.4M+3.0%$47.0M+0.1%$46.9M-3.4%$48.6M-6.2%$51.8M-9.2%$57.0M-4.1%$59.5M-4.0%$62.0M
Goodwill$540.7M+0.4%$538.3M+1.0%$533.1M+1.3%$526.1M-2.8%$541.2M+0.2%$540.0M+1.7%$530.8M-1.0%$535.9M-0.3%$537.8M+1.0%$532.7M+1.6%$524.4M-2.2%$536.3M-0.4%$538.3M+1.1%$532.3M+5.2%$505.9M
Total Liabilities$2.1B-4.0%$2.2B-2.4%$2.2B-2.9%$2.3B-11.0%$2.6B-10.9%$2.9B+33.4%$2.2B-8.8%$2.4B-3.9%$2.5B+2.3%$2.4B+0.7%$2.4B+1.7%$2.4B+4.3%$2.3B+3.3%$2.2B+12.0%$1.9B
Current Liabilities$576.0M-2.8%$592.7M+2.3%$579.3M-13.3%$667.9M+0.5%$664.9M+18.0%$563.4M+23.5%$456.1M-7.1%$491.2M-14.2%$572.6M+17.2%$488.7M-0.6%$491.7M+6.1%$463.5M-14.6%$542.7M+13.7%$477.4M+3.8%$460.0M
Long-Term Debt$862.0M-11.9%$978.3M-8.2%$1.1B-1.6%$1.1B-21.7%$1.4B-23.1%$1.8B+12.7%$1.6B-9.9%$1.8B-0.2%$1.8B-0.6%$1.8B-0.2%$1.8B+0.1%$1.8B+10.7%$1.6B-0.2%$1.6B+14.6%$1.4B
Total Equity$794.2M+26.4%$628.5M+23.5%$508.7M+73.3%$293.6M+4.6%$280.7M+1717.9%$15.4M+125.6%-$60.3M+77.5%-$268.6M+26.1%-$363.6M-31.7%-$276.2M+7.3%-$297.8M+14.2%-$347.1M-14.4%-$303.5M-163.7%-$115.1M+47.4%-$219.0M
Retained Earnings$898.1M+21.2%$740.7M+18.6%$624.8M+41.9%$440.2M+23.3%$357.0M+204.8%$117.1M+109.9%$55.8M+131.0%-$179.8M+36.5%-$283.1M-59.4%-$177.6M+18.8%-$218.7M+31.7%-$320.1M+16.9%-$385.1M+40.4%-$646.2M+26.5%-$879.3M

SBH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SBH annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$368.3M$274.8M+11.5%$246.5M-1.1%$249.3M+59.3%$156.5M-59.0%$381.9M-10.5%$426.9M+33.2%$320.4M-14.0%$372.7M+8.6%$343.3M-3.1%$354.1M+17.7%$300.8M-4.8%$316.0M+1.8%$310.5M+4.3%$297.6M+2.0%$291.8M
Capital Expenditures$127.1M$102.1M+1.0%$101.2M+11.5%$90.7M-8.6%$99.3M+34.3%$73.9M-33.3%$110.9M+2.9%$107.8M+24.6%$86.5M-3.5%$89.7M-40.7%$151.2M+41.9%$106.5M+39.2%$76.6M-9.7%$84.8M+22.9%$69.0M+15.8%$59.6M
Free Cash Flow$241.2M$172.7M+18.8%$145.4M-8.3%$158.6M+177.0%$57.3M-81.4%$308.0M-2.6%$316.0M+48.6%$212.7M-25.7%$286.2M+12.8%$253.6M+25.0%$202.9M+4.4%$194.3M-18.9%$239.4M+6.1%$225.7M-1.3%$228.6M-1.6%$232.3M
Investing Cash Flow-$129.6M-$58.3M+46.5%-$108.9M-9.2%-$99.8M+2.6%-$102.4M-34.7%-$76.0M+38.6%-$123.8M-29.1%-$95.9M-0.6%-$95.3M-6.3%-$89.6M+48.7%-$174.8M-55.0%-$112.8MN/AN/AN/AN/A
Financing Cash Flow-$179.1M-$178.4M-16.1%-$153.7M-52.5%-$100.8M+73.0%-$373.7M+11.0%-$420.0M-400.5%$139.8M+160.9%-$229.3M+12.9%-$263.3M+5.1%-$277.3M-19.5%-$232.1M-52.8%-$152.0MN/AN/AN/AN/A
Share Buybacks$92.6M$54.0M-10.6%$60.4M+298.6%$15.2M-88.4%$130.3MN/A$61.4M+29.4%$47.4M-71.5%$166.7M-51.9%$346.9M+65.9%$209.1M-8.1%$227.6M-31.7%$333.3M-34.6%$509.7M+154.9%$200.0MN/A

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SBH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SBH annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin51.6%+0.8pp50.9%-0.1pp50.9%+0.6pp50.3%-0.1pp50.4%+1.6pp48.8%-0.5pp49.3%-0.2pp49.4%-0.5pp49.9%+0.2pp49.7%+0.2pp49.5%-0.1pp49.6%0.0pp49.6%+0.1pp49.5%+0.7pp48.8%
Operating Margin8.9%+1.2pp7.6%-1.1pp8.7%-0.1pp8.8%-2.0pp10.8%+3.4pp7.4%-4.5pp11.8%+1.0pp10.8%-1.3pp12.2%-0.5pp12.6%-0.3pp12.9%-0.6pp13.5%-0.9pp14.4%+0.2pp14.2%+0.5pp13.7%
Net Margin5.3%+1.2pp4.1%-0.8pp5.0%+0.1pp4.8%-1.4pp6.2%+0.9pp5.3%-1.8pp7.0%+0.4pp6.6%+1.1pp5.5%-0.2pp5.6%-0.5pp6.1%-0.4pp6.6%-0.7pp7.2%+0.6pp6.6%+0.1pp6.5%
Return on Equity24.7%+0.3pp24.4%-11.9pp36.3%-26.2pp62.5%-22.9pp85.4%-1109.9pp1195.4%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Return on Assets6.8%+1.3pp5.5%-1.3pp6.8%-0.4pp7.1%-1.3pp8.4%+2.0pp6.4%-6.6pp12.9%+0.6pp12.3%+2.1pp10.3%-0.4pp10.6%-0.6pp11.2%-1.1pp12.3%-1.3pp13.6%+2.3pp11.3%-1.1pp12.4%
Current Ratio2.26+0.1x2.20+0.1x2.12+0.4x1.70-0.4x2.08-0.5x2.540.0x2.55+0.2x2.35+0.4x1.99-0.4x2.400.0x2.410.0x2.38+0.5x1.87-0.6x2.44+0.5x1.91
Debt-to-Equity1.09-0.5x1.56-0.5x2.10-1.6x3.69-1.2x4.92-111.4x116.36N/AN/AN/AN/AN/AN/AN/AN/AN/A
FCF Margin4.7%+0.8pp3.9%-0.3pp4.3%+2.8pp1.5%-6.5pp8.0%-1.0pp9.0%+3.5pp5.5%-1.8pp7.3%+0.8pp6.4%+1.3pp5.1%+0.1pp5.1%-1.3pp6.4%+0.1pp6.2%-0.3pp6.5%-0.6pp7.1%

Similar Companies

Frequently Asked Questions

What is Sally Beauty Hldgs's annual revenue?

Sally Beauty Hldgs (SBH) reported $3.7B in total revenue for fiscal year 2025. This represents a -0.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Sally Beauty Hldgs's revenue growing?

Sally Beauty Hldgs (SBH) revenue declined by 0.4% year-over-year, from $3.7B to $3.7B in fiscal year 2025.

Is Sally Beauty Hldgs profitable?

Yes, Sally Beauty Hldgs (SBH) reported a net income of $195.9M in fiscal year 2025, with a net profit margin of 5.3%.

Sally Beauty Hldgs (SBH) reported diluted earnings per share of $1.89 for fiscal year 2025. This represents a 32.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sally Beauty Hldgs (SBH) had EBITDA of $427.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Sally Beauty Hldgs (SBH) had $149.2M in cash and equivalents against $862.0M in long-term debt.

Sally Beauty Hldgs (SBH) had a gross margin of 51.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Sally Beauty Hldgs (SBH) had an operating margin of 8.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Sally Beauty Hldgs (SBH) had a net profit margin of 5.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Sally Beauty Hldgs (SBH) has a return on equity of 24.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Sally Beauty Hldgs (SBH) generated $172.7M in free cash flow during fiscal year 2025. This represents a 18.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Sally Beauty Hldgs (SBH) generated $274.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Sally Beauty Hldgs (SBH) had $2.9B in total assets as of fiscal year 2025, including both current and long-term assets.

Sally Beauty Hldgs (SBH) invested $102.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Sally Beauty Hldgs (SBH) spent $54.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Sally Beauty Hldgs (SBH) had 97M shares outstanding as of fiscal year 2025.

Sally Beauty Hldgs (SBH) had a current ratio of 2.26 as of fiscal year 2025, which is generally considered healthy.

Sally Beauty Hldgs (SBH) had a debt-to-equity ratio of 1.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Sally Beauty Hldgs (SBH) had a return on assets of 6.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Sally Beauty Hldgs (SBH) has an Altman Z-Score of 2.86, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Sally Beauty Hldgs (SBH) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Sally Beauty Hldgs (SBH) has an earnings quality ratio of 1.40x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Sally Beauty Hldgs (SBH) has an interest coverage ratio of 5.09x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Sally Beauty Hldgs (SBH) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top